{"nct_id":"NCT00773344","title":"Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin","status":"COMPLETED","status_verified_date":"2015-10","start_date":"2005-12","start_date_type":null,"primary_completion_date":"2009-05","primary_completion_date_type":"ACTUAL","completion_date":"2009-08","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["BMY"]}